Vistim Labs Closes First Round of Funding
May 11, 2023
Altitude Lab recently announced that Vistim Labs, one of their current first year companies, has successfully closed its seed round, oversubscribed at $800,000. According to Altitude’s report, completing this round will finance Vistim’s go-to-market this year and allow them to raise another $2M this fall to scale their sales in 2024.
Recent News
- Merit Medical Acquires Biolife Delaware
- Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
- BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
- KyphoLift Debuts at ISMRM 2025: Transforming Patient Positioning for Safer, More Accurate Imaging
- Kelvyn Cullimore: An Unfair Penalty on Life-Saving Pills
- Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis